ESLA: SEC Form SCHEDULE 13G filed by Estrella Immunopharma Inc.
Stocks in this Quantisnow insightHealth Care
Historical context for ESLA
Across the 8 sessions after earlier ESLA headlines, the stock closed higher 4 times and lower 4 times, with a median move of 5.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ESLA | SPY |
|---|---|---|---|
| May 5, 2026 | Estrella Immunopharma to Participate in the D. Boral Capital Global Conference | -8.1% | +0.8% |
| Mar 23, 2026 | Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research | -1.9% | +1.1% |
| Feb 9, 2026 | Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR® | -1.7% | +0.5% |
| Feb 3, 2026 | Estrella Immunopharma Announces Late-Breaking Oral Presentation of Phase 1 STARLIGHT-1 Data for EB103 at the 2026 Tandem Meetings of ASTCT® & CIBMTR® | +7.3% | -0.8% |
| Jan 6, 2026 | Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Private Placement | +3.0% | +0.6% |
| Jan 5, 2026 | Estrella Immunopharma, Inc. Announces $8.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules | -4.3% | +0.7% |
Quantisnow market dataNASDAQ
ESLA
Estrella Immunopharma Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2021
Get push alerts for ESLA
Full ESLA profile on Quantisnow Follow ESLA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time